Abstract
Odds ratios were not significantly different by gender, age, or education years. Frequency of use was low, with a mean of 5.4 times/year. Conclusions: A clinically significant proportion of treatment seeking substance users reported infrequent synthetic cannbinoid use. Less than full-time employment and Black race may be risk factors for use; marijuana smoking did not appear to increase risk. Asking about use can identify patients who may benefit from continued monitoring, however more extensive toxicology screening is not supported. Financial Support: Supported by: National Institutes on Drug Abuse (DA009236), National Institutes on Drug Abuse (T32DA007294-19).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
